Innovator Equity Defined Protection ETF - 2 Yr to October 2026AOCT

The Innovator Equity Defined Protection ETF, ticker AOCT, is a two-year defined-outcome ETF due to expire in October 2026. It is structured to cap losses over the protection period while allowing upside participation, but the SEC filing provides no detail on the index composition or the strike level beyond the mandate itself. The fund’s expense ratio sits at 2%, which is the financial equivalent of a personal trainer taking 2% of your annual salary for the privilege of standing in the gym with you. The Nasdaq listing confirms the ticker is live and tradable, but offers no insight into the basket’s construction or the liquidity mechanism when volatility spikes. In short, the marketing sells peace of mind, but the reality is a fee-driven wrapper around an index whose inner workings remain undisclosed beyond the filing date.

The fund’s premise is simple: protect investors from losses while giving them a slice of the upside, a pitch that sounds like a financial Swiss Army knife-useful, compact, and somehow always missing the one tool you actually need. The SEC’s EDGAR search confirms AOCT exists and is filed under Innovator’s defined-protection suite, but the filing does not specify the index provider, the protection level, or the rebalancing schedule. This opacity is not unusual for defined-outcome ETFs, but it does mean that the only concrete figure investors can anchor to is the 2% fee. The Nasdaq page confirms the ticker is active, but offers no volume, spread, or AUM data that would reassure sceptics that the product is liquid enough to exit in a hurry.

The fund’s marketing materials, which are not part of the SEC filing, likely emphasise the protection feature and the thematic appeal of “defined outcomes,” but the SEC’s search shows no attached prospectus or SAI that would let investors drill into the index rules. The FINRA Fund Analyzer, which crunches expense ratios and fee drag, confirms the 2% charge but cannot tell you how the protection mechanism performs in stress scenarios because those scenarios are not part of its mandate. For now, AOCT is a ticker with a fee and a promise, but the evidence trail stops short of proving the protection works as advertised when markets misbehave.

The chart route for AOCT is available via Nasdaq, but the source list does not provide a TradingView embed or specific price levels. The fund’s NAV and market price will reflect the daily mark-to-market of the underlying index plus the 2% fee drag, but the Nasdaq listing does not disclose whether the fund trades at a premium or discount to NAV or how often the basket is rebalanced. The FINRA tool confirms the fee structure, but the SEC filing does not supply the index rules that would let an outsider model the payoff at expiry. Without a prospectus detailing the index provider and the strike logic, AOCT’s defined protection remains a marketing claim rather than a verifiable outcome.

What changed today? The Nasdaq page shows the ticker is live and trading, but the source list provides no news event, earnings update, or filing amendment specific to AOCT on 2026-07-26. The fund’s performance and spread will be driven by the daily price action of the underlying index, which is not named in the evidence. The fee remains the only hard number in the file. The evidence does not prove the protection level, the index rules, or the liquidity profile, which means investors are buying a fee and a promise rather than a transparent product.

The evidence gap here is meaningful. A prospectus attached to the SEC filing would reveal the index provider, the protection strike, the rebalancing schedule, and the historical backtest. A Nasdaq depth-of-market feed would show the bid-ask spread and average daily volume. A FINRA breakdown of the fund’s top holdings would reveal the concentration risk. None of this is supplied in the source list. Until those gaps are filled, AOCT remains a glossy wrapper around an undisclosed basket with a 2% haircut: pretty, but ultimately opaque.